Enlivex Therapeutics Ltd. Logo

Enlivex Therapeutics Ltd.

ENLV | TA

Overview

Corporate Details

ISIN(s):
IL0011319527
LEI:
Country:
Israel
Address:
Weizmann Science Park, 14 Einstein St., 7403618 Ness Ziona
Sector:
Health Care
Industry:
Biotechnology

Description

Enlivex develops immunotherapy solutions for inflammatory diseases and critical conditions.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2022-12-07 14:40
Regulatory News Service
A Novel Immunotherapy That Could Bring Hope To Millions Of Sepsis Patients Rece…
English 14.8 KB
2022-12-06 14:00
Regulatory News Service
What's Next For Cell Therapy In Oncology? Enlivex (NASDAQ: ENLV) Says It Has Th…
English 13.8 KB
2022-12-02 14:00
Regulatory News Service
First Patients Dosed in Phase I/II Trial of Enlivexs Off-the-Shelf Cell Therapy…
English 15.9 KB
2022-12-01 20:00
Regulatory News Service
Israeli Ministry Of Health Clears Way For Human Trials Of AllocetraTM, A Propri…
English 15.3 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BSF ENTERPRISE PLC Logo BSF ENTERPRISE PLC United Kingdom BSFA
Can-Fite BioPharma Ltd. Logo Can-Fite BioPharma Ltd. Israel CANF
Cantargia Logo Cantargia Sweden CANTA
Captor Therapeutics S.A. Logo Captor Therapeutics S.A. Poland CTX
Carbiotix AB Logo Carbiotix AB Sweden CRBX
Cellectis Logo Cellectis France ALCLS
CELLULAR GOODS PLC Logo CELLULAR GOODS PLC United Kingdom CBX
Celyad Oncology SA Logo Celyad Oncology SA Belgium CYAD
Cereno Scientific AB Logo Cereno Scientific AB Sweden CRNO
Cessatech A/S Logo Cessatech A/S Denmark CESSA